A Study of the Use of Text Message Reminders to Take Palbociclib
Running, not enrolling · Not applicable
Conditions studied: Breast Cancer
In brief
The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.
Key facts
- Study ID
- NCT04216576
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 45
- Starts
- 2019-12-27
- Expected to finish
- 2026-12-27
- Last updated by the study team
- 2026-03-27
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance)
- >/= 18 years of age
- Able to speak, read and write English
- Willingness and ability to send and receive text messages with intervention app
- Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application
- Criteria applicable for both Control and Intervention groups
- Flip-phones do not support OhMD Application and thus ineligible to participate
- Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex)
You may not qualify if…
- History of taking palbociclib (Ibrance)
- Patients whose caregivers coordinate their health care
Where it is running
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (Limited Protocol Activities) — Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) — Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited protocol activities) — Rockville Centre, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.